Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal Mutiara Medika: Jurnal Kedokteran dan Kesehatan
Pramono, Bagus Andi
Unknown Affiliation
Health Professions Medicine & Pharmacology

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Anticoagulant Therapy in Moderate to Severe COVID-19 Patients Achmad, Agus Fitriyanto; Raharjani, Yuni Iswati; Setyaningrum, Zidni; Pramono, Bagus Andi; Selvyana, Dita Ria; Negoro, Sri Pramesthi Wisnu Bowo
Mutiara Medika: Jurnal Kedokteran dan Kesehatan Vol 22, No 1 (2022): January
Publisher : Universitas Muhammadiyah Yogyakarta

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.18196/mmjkk.v22i1.11634

Abstract

Coronavirus disease-19 (COVID-19) has a spectrum of severity from no symptoms to serious complications. Coagulopathy is a serious complication of COVID-19, and that condition is a marker of poor prognosis. Anticoagulant drugs are often used as prophylaxis and thrombosis therapy to treat COVID-19 patients. Anticoagulant therapy is indicated for moderate-severe COVID-19 patients. Low molecular weight heparin (LMWH) and Unfractionated Heparin (UFH) are anticoagulant drugs of choice for prophylaxis and thrombosis therapy in COVID-19 patients. When administering anticoagulant drugs, monitoring bleeding, renal function, and platelet count needs to be done, even if only as thromboprophylaxis. LMWH and UFH have good clinical efficacy with minimal side effects in managing COVID-19 patients.
Co-Authors Achmad, Agus Fitriyanto Negoro, Sri Pramesthi Wisnu Bowo Raharjani, Yuni Iswati Selvyana, Dita Ria Setyaningrum, Zidni